Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing genetic technologies. Two ethical issues

T H Murray1

  • 1Case Western Reserve University.

International Journal of Technology Assessment in Health Care
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug Testing and Moral Responsibility.

The Physician and sportsmedicine·2016
Same author

Human Growth Hormone in Sports: No.

The Physician and sportsmedicine·2016
Same author

Guest Editorial.

The Physician and sportsmedicine·2016
Same author

Doping in sport: challenges for medicine, science and ethics.

Journal of internal medicine·2008
Same author

The ethics of the use of technologically constructed high-altitude environments to enhance performances in sport.

Scandinavian journal of medicine & science in sports·2007
Same author

Genetic ties and genetic mixups.

Journal of medical ethics·2003
Same journal

Measuring, Valuing, and Incorporating Patient and Caregiver Productivity Costs in Economic Evaluations: A Scoping Review and Environmental Scan.

International journal of technology assessment in health care·2026
Same journal

ASSESSING COST EFFECTIVENESS IN ONCOLOGY TREATMENT SEQUENCES: A REVIEW OF PATHWAY MODELLING METHODS FOR HEALTH TECHNOLOGY ASSESSMENT.

International journal of technology assessment in health care·2026
Same journal

Practice and challenges of HB-HTA in China: insights from hospital management and clinical perspectives.

International journal of technology assessment in health care·2026
Same journal

Policy Dialogue on Health Technology Assessment in Middle East and North Africa: Reporting from an HTAi initiative.

International journal of technology assessment in health care·2026
Same journal

What is new in the early health technology assessment's new definition?

International journal of technology assessment in health care·2026
Same journal

Incorporating climate impact in health care decisions: new criteria to be tested in the Netherlands.

International journal of technology assessment in health care·2026
See all related articles

Understanding the social context of genetics is crucial for assessing ethical issues in genetic technologies. Contemporary genetics presents challenges, questioning assumptions about choice and improvement, especially in reproduction and therapy versus enhancement.

Area of Science:

  • Genetics
  • Bioethics
  • Sociology

Background:

  • Assessing genetic technologies necessitates understanding their ethical implications and social context.
  • Contemporary genetics is shaped by societal factors and underlying presumptions.

Purpose of the Study:

  • To discuss 10 factors characterizing the social context of contemporary genetics.
  • To examine two common presumptions: 'more choice is always better' and 'what can be improved should be improved'.

Main Methods:

  • Literature review and conceptual analysis of social and ethical dimensions of genetic technologies.
  • Examination of case studies in genetic screening and testing.

Main Results:

  • Genetic screening and testing for reproductive choice yield ambiguous benefits.
Keywords:
Genetics and Reproduction

Related Experiment Videos

  • Nondirective counseling in prenatal testing becomes problematic with a growing test menu.
  • Increased reproductive choice may shift responsibility towards ensuring genetically 'healthy' offspring.
  • Genetic technologies blur the line between therapy and enhancement, with potential for non-health-related applications.

    • Conclusions:

    • The social context significantly influences the ethical landscape of genetic technologies.
    • Assumptions about choice and improvement in genetics require critical re-evaluation.
    • Future genetic technologies will increasingly challenge the therapy-enhancement distinction, demanding careful ethical consideration.